Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.
Keywords: C‐peptide; diabetes mellitus; immune checkpoint inhibitor; insulin secretion.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.